S. Styren

发表

Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34

David H. Hall, William E. Klunk, Chester A. Mathis, 2001, Neurobiology of Aging.

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment

S. Wisniewski, D. Bennett, L. Beckett, 2002, Annals of neurology.

Structural correlates of cognition in dementia: quantification and assessment of synapse change.

S. DeKosky, S. Scheff, S. Styren, 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

Up‐Regulation of Type 2 Iodothyronine Deiodinase mRNA in Reactive Astrocytes Following Traumatic Brain Injury in the Rat

P. Kochanek, S. DeKosky, S. Styren, 1998, Journal of neurochemistry.

Alternate strategies in lesion-induced reactive synaptogenesis: differetial expression of L1 in two populations of sprouting axons

S. DeKosky, C. Lagenaur, S. Styren, 1995, Experimental Neurology.

Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease

Qinying Zhao, M. Bednar, A. Burstein, 2013, Clinical neuropharmacology.

Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants.

S. DeKosky, C. Olanow, J. Kordower, 1997, Cell transplantation.

Hypothermia attenuates the normal increase in interleukin 1 beta RNA and nerve growth factor following traumatic brain injury in the rat.

P. Kochanek, D. Marion, S. DeKosky, 1995, Journal of neurotrauma.

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy

C. Jack, K. Kantarci, Qinying Zhao, 2017, Alzheimer's & dementia.

Complement activation by f8-amyloid in Alzheimer disease

P. Mcgeer, B. Bradt, I. Lieberburg, 2022 .

Cholinergic Changes and Synaptic Alterations in Alzheimer’s Disease

S. DeKosky, S. Styren, M. O’Malley, 1994 .

Interleukm‐1 receptor antagonist suppresses neurotrophin response in injured rat brain

P. Kochanek, D. Marion, S. DeKosky, 1996, Annals of neurology.

Expression of fetal ALZ‐50 reactive clone 1 (FAC1) in dentate gyrus following entorhinal cortex lesion

S. DeKosky, R. Bowser, S. Styren, 1997, The Journal of comparative neurology.

Rapid expression and transport of embryonic N‐CAM in dentate gyrus following entorhinal cortex lesion: Ultrastructural analysis

S. DeKosky, C. Lagenaur, S. Styren, 1994, The Journal of comparative neurology.

X-34, A Fluorescent Derivative of Congo Red: A Novel Histochemical Stain for Alzheimer's Disease Pathology

W. Klunk, S. Styren, R. Hamilton, 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Complement activation by beta-amyloid in Alzheimer disease.

P. Mcgeer, B. Bradt, N. Cooper, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease

S. Styren, W. H. Civin, J. Rogers, 1988, Neurobiology of Aging.

Severe controlled cortical impact in rats: assessment of cerebral edema, blood flow, and contusion volume.

P. Kochanek, J. Schiding, D. Marion, 1995, Journal of neurotrauma.

Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies

J. Pariente, R. Black, A. Ivanoiu, 2016, Alzheimer's Research & Therapy.

PF-04447943, a novel PDE9A inhibitor, increases cGMP levels in cerebrospinal fluid: Translation from non-clinical species to healthy human volunteers

B. Corrigan, H. Soares, T. Nicholas, 2009, Alzheimer's & Dementia.

Human casein kinase Iδ phosphorylation of human circadian clock proteins period 1 and 2

O. Khorkova, D. Virshup, S. Styren, 2001, FEBS letters.

Epidermal growth factor receptor expression in demented elderly: localization to vascular endothelial cells of brain, pituitary and skin

S. DeKosky, E. Mufson, S. Styren, 1993, Brain Research.

Epidermal growth factor receptor expression in demented and aged human brain

E. Mufson, S. Styren, W. H. Civin, 1990, Brain Research.

Traumatic Brain Injury‐Induced Excitotoxicity Assessed in a Controlled Cortical Impact Model

D. Marion, S. DeKosky, S. Styren, 1993, Journal of neurochemistry.

Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain

S. Styren, W. H. Civin, J. Rogers, 1990, Experimental Neurology.

Dementia associated with dorsal midbrain lesion

K. Meador, S. DeKosky, D. Loring, 1996, Journal of the International Neuropsychological Society.

Expression of differential immune factors in temporal cortex and cerebellum: The role of α‐1‐antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease

S. DeKosky, M. Kamboh, S. Styren, 1998, The Journal of comparative neurology.

Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.

E. Liu, Kaori Ito, B. Corrigan, 2016, Journal of Alzheimer's disease : JAD.

Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.

S. Leurgans, D. Bennett, S. DeKosky, 2003, Archives of neurology.

The Type 1 Interleukin-1 Receptor Is Essential for the Efficient Activation of Microglia and the Induction of Multiple Proinflammatory Mediators in Response to Brain Injury

S. DeKosky, S. Levison, A. Basu, 2002, The Journal of Neuroscience.

Upregulation of Nerve Growth Factor Following Cortical Trauma

P. Kochanek, D. Marion, S. DeKosky, 1994, Experimental Neurology.

Astrocytes Are the Major Source of Nerve Growth Factor Upregulation Following Traumatic Brain Injury in the Rat

Steven T. DeKosky, P. Kochanek, S. DeKosky, 1998, Experimental Neurology.

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab

Kaori Ito, B. Corrigan, H. Brashear, 2015, Alzheimer's & dementia.

Safety and pharmacokinetics following a single 10-minute intravenous infusion of the anti-amyloid mAb ponezumab (PF-04360365) in patients with mild to moderate Alzheimer's disease

Qinying Zhao, M. Bednar, A. Burstein, 2010, Alzheimer's & Dementia.

Effect of ponezumab on CSF biomarkers: Pooled analysis of phase IIa studies in subjects with mild-to-moderate Alzheimer's disease

Henrik Zetterberg, Kaj Blennow, K. Blennow, 2012, Alzheimer's & Dementia.

Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials

Kaori Ito, B. Corrigan, H. Brashear, 2015, Alzheimer's & dementia.

Fetal Grafting for Parkinson's Disease: Expression of Immune Markers in Two Patients with Functional Fetal Nigral Implants

S. DeKosky, C. Olanow, J. Kordower, 1997 .

Safety, efficacy, pharmacokinetics and pharmacodynamics of multiple doses of Ponezumab in subjects with mild-to-moderate Alzheimer's disease

C. Jack, M. Bednar, A. Burstein, 2012, Alzheimer's & Dementia.

Epidermal Growth Factor Receptor Expression in Skin Does Not Predict Dementia in the Elderly

S. DeKosky, S. Styren, Gisele C. Styren, 1997, Dementia and Geriatric Cognitive Disorders.